Takalani A
ORCID: 0000-0001-5136-4208
· 1 paper in corpus
other
2022
BACKGROUND: The Janssen-Ad26.COV2.S vaccine is authorized for use in several countries, with more than 30 million doses administered. Mild and severe allergic adverse events following immunization (AEFI) have been reported. OBJECTIVE: We s…